{"id":"clanobutin","rwe":[{"pmid":"40475030","year":"2025","title":"Assessment of an integrated therapeutic protocol for sheep with acute ruminal impaction: diagnostic and prognostic significance of rumen functions and hepatorenal biomarkers.","finding":"","journal":"Frontiers in veterinary science","studyType":"Clinical Study"},{"pmid":"39644820","year":"2025","title":"Profiteering optical biosensors for swift assaying clanobutin residues in food samples, baby food and surface water: Comparative greenness, whiteness and blueness assessment.","finding":"","journal":"Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy","studyType":"Clinical Study"},{"pmid":"29548468","year":"2018","title":"Corrigendum to \"Simultaneous determination of clanobutin, dichlorvos, and naftazone in pork, beef, chicken, milk, and egg using liquid chromatography-tandem mass spectrometry\" [Food Chem. 252C (2018) 40-48].","finding":"","journal":"Food chemistry","studyType":"Clinical Study"},{"pmid":"29478562","year":"2018","title":"Simultaneous determination of clanobutin, dichlorvos, and naftazone in pork, beef, chicken, milk, and egg using liquid chromatography-tandem mass spectrometry.","finding":"","journal":"Food chemistry","studyType":"Clinical Study"},{"pmid":"15359962","year":"2004","title":"Nonfatal splenic haematoma and pancytopenia in an ass.","finding":"","journal":"Australian veterinary journal","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"bykahepar","offLabel":[],"synonyms":["clanobutin","bykahepar","clanobutine"],"timeline":[],"approvals":[],"brandName":"Bykahepar","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like a factory with many different machines working together. Bykahepar is like a tool that fits into one of these machines, changing how it works to produce a desired effect. This can help to slow down or speed up certain processes in the body, depending on the specific goal of the treatment.","oneSentence":"Bykahepar works by binding to and altering the activity of specific proteins or enzymes in the body.","technicalDetail":"Bykahepar is a small molecule that likely acts as a competitive inhibitor or allosteric modulator of its target protein, altering its activity and leading to a therapeutic effect."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3104","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CLANOBUTIN","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:03:48.990313","biosimilars":[],"competitors":[],"genericName":"clanobutin","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"W6Y945055S","CHEBI":"CHEBI:135471","INN_ID":"2907","UMLSCUI":"C0055854","ChEMBL_ID":"CHEMBL2107589","KEGG_DRUG":"D07708","PUBCHEM_CID":"35378","MESH_SUPPLEMENTAL_RECORD_UI":"C019159"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":19,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2025","pmid":"40475030","title":"Assessment of an integrated therapeutic protocol for sheep with acute ruminal impaction: diagnostic and prognostic significance of rumen functions and hepatorenal biomarkers.","journal":"Frontiers in veterinary science"},{"date":"2025 Mar 15","pmid":"39644820","title":"Profiteering optical biosensors for swift assaying clanobutin residues in food samples, baby food and surface water: Comparative greenness, whiteness and blueness assessment.","journal":"Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy"},{"date":"2018 Jul 15","pmid":"29548468","title":"Corrigendum to \"Simultaneous determination of clanobutin, dichlorvos, and naftazone in pork, beef, chicken, milk, and egg using liquid chromatography-tandem mass spectrometry\" [Food Chem. 252C (2018) 40-48].","journal":"Food chemistry"},{"date":"2018 Jun 30","pmid":"29478562","title":"Simultaneous determination of clanobutin, dichlorvos, and naftazone in pork, beef, chicken, milk, and egg using liquid chromatography-tandem mass spectrometry.","journal":"Food chemistry"},{"date":"2004 Aug","pmid":"15359962","title":"Nonfatal splenic haematoma and pancytopenia in an ass.","journal":"Australian veterinary journal"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Bykahepar, also known as Clanobutin, is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it is not known if it is FDA approved or off-patent. The approved indications for Bykahepar are also unknown. As a small molecule, it is likely to work by interacting with specific biological molecules to produce a therapeutic effect. Further research is needed to fully understand its mechanism of action and safety profile.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}